author-photo

Anna Hultberg

Utrecht University

37

Papers

550

Citations

Citation Trend

Filter By

Papers (29) Sort By

Journal Conference Others

Safety and Efficacy of Cusatuzumab in Combination with Venetoclax and Azacitidine (CVA) in Patients with Previously Untreated Acute Myeloid Leukemia (AML) Who Are Not Eligible for Intensive Chemotherapy; An Open-Label, Multicenter, Phase 1b Study

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
The NHance ® Mutation-Equipped Anti-MET Antibody ARGX-111 Displays Increased Tissue Penetration and Anti-Tumor Activity in Advanced Cancer Patients.

2021 Biomedicines
Show All
- Source
- Cite
- Save
Citations (0)
Cusatuzumab for treatment of CD70-positive relapsed or refractory cutaneous T-cell lymphoma.

2021 Cancer
Show All
- Source
- Cite
- Save
Citations (0)
The Combination of the BCL-2 Antagonist Venetoclax with the CD70-Targeting Antibody Cusatuzumab Synergistically Eliminates Primary Human Leukemia Stem Cells

2019 Blood
Show All
- Source
- Cite
- Save
Citations (3)
Argx-110 Targeting CD70, in Combination with Azacitidine, Shows Favorable Safety Profile and Promising Anti-Leukemia Activity in Newly Diagnosed AML Patients in an Ongoing Phase 1/2 Clinical Trial

2018 Blood
Show All
- Source
- Cite
- Save
Citations (10)
Phase I dose-escalation study of the anti-CD70 antibody ARGX-110 in advanced malignancies

2017 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (23)
CD70 EXPRESSION IN CUTANEOUS T CELL LYMPHOMA (CTCL) PATIENTS AND MECHANISMS OF ACTION OF ARGX-110 IN SKIN: HISTOPATHOLOGICAL AND CLINICAL DATA

2017 Hematological Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Neutralization of Clostridium difficile Toxin B Mediated by Engineered Lactobacilli That Produce Single-Domain Antibodies

2016 Infection and Immunity
Show All
- Source
- Cite
- Save
Citations (28)
Dual anti-idiotypic purification of a novel, native-format biparatopic anti-MET antibody with improved in vitro and in vivo efficacy

2016 Scientific Reports
Show All
- Source
- Cite
- Save
Citations (13)
Abstract P2-05-17: ARGX-111 depletes MET-expressing circulating tumor cells via enhanced ADCC, resulting in inhibition of metastasis

2016 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)